PDT Partners’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,975
Closed -$230K 1148
2021
Q4
$230K Sell
4,975
-1,110
-18% -$63.8K 0.02% 740
2021
Q3
$407K Buy
6,085
+1,385
+29% +$114K 0.03% 519
2021
Q2
$501K Buy
+4,700
New +$557K 0.03% 517

Other funds holding TECX

PDT Partners's TECX Position: Q1 2022 in Review

PDT Partners sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 4,975 shares — an estimated $230K sold.

PDT Partners first reported a position in TECX in Q2 2021 and held it in 3 quarters. The position peaked at $501K in Q2 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • PDT Partners reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 4,975 Tectonic Therapeutic shares in Q1 2022, an estimated $230K.
  • PDT Partners first reported a position in Tectonic Therapeutic in Q2 2021 and held it in 3 quarters.
  • PDT Partners's Tectonic Therapeutic position peaked at $501K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.